Antibody-Drug Conjugates Face Clinical Resistance and Toxicity Challenges in Solid Tumors
A review in Molecular Cancer examines how antibody-drug conjugates treat solid tumors while addressing clinical resistance, toxicity profiles, and narrow ...
A review in Molecular Cancer examines how antibody-drug conjugates treat solid tumors while addressing clinical resistance, toxicity profiles, and narrow ...
Researchers synthesize how coordinated epigenetic, transcriptional, and epitranscriptomic regulatory layers reshape alternative RNA splicing to drive pancreatic ductal adenocarcinoma progression ...
A carborane-quinazoline hybrid derived from erlotinib delivered boron to tumor cells far more efficiently than BPA and delayed tumor growth ...
A comprehensive Molecular Cancer review explains how antibody-drug conjugates deliver lethal payloads to tumors, why resistance emerges, and which next-generation ...
In a groundbreaking development that promises to redefine the landscape of cancer therapy, a team of researchers has unveiled a ...
In a groundbreaking study published in “Genome Medicine,” researchers have unveiled significant insights into breast cancer biology, particularly focusing on ...
In the ever-evolving landscape of cancer research, a groundbreaking study has emerged that elucidates a novel mechanism linking the loss ...
Recent breakthroughs in cancer research have revealed novel therapeutic strategies that hold significant promise for the treatment of various malignancies. ...
In the evolving landscape of oncology research, the intricate molecular mechanisms that drive the progression of ovarian cancer continue to ...
In the relentless quest to conquer cancer, researchers have long sought molecular targets that can be precisely manipulated to halt ...
In the rapidly evolving field of oncology, one of the most persistent challenges remains understanding the intricate biological mechanisms that ...
In a compelling advancement for liver cancer therapeutics, researchers have unveiled a novel molecular axis involving Fibroblast Growth Factor 1 ...
In a groundbreaking study published in Nature, researchers have unveiled the pivotal role of specific genetic elements in preserving extrachromosomal ...
In the rapidly evolving landscape of oncology, the integration of nanotechnology has opened promising avenues for the diagnosis and treatment ...
In a groundbreaking development that could redefine cancer therapy, researchers have unveiled a novel approach to delivering topoisomerase I (top1) ...
In a remarkable stride forward in cancer therapeutics, researchers have unveiled a groundbreaking strategy to target and degrade YAP, a ...
In recent years, the urgency to combat human papillomavirus (HPV) related cervical cancer has led scientists to explore innovative therapeutic ...
In recent years, the convergence of nanotechnology and medical science has opened new avenues for targeted therapy, leading to innovative ...
A groundbreaking development in cancer therapeutics has emerged from the collaborative efforts of Georgia State University researchers and the biotech ...
In the ever-evolving field of cancer treatment, a groundbreaking approach is coming to light, unveiled by a recent study focused ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.